2024-10-14 13:31:07
Listed among the limitations of the study cited in the article is this important caveat: "the population prevalence of pediatric PASC cannot be determined with the current design because participants with more prolonged symptoms may have been more inclined to enroll." [Link][Link] NEEDS_MORE_RATINGS(13-3-10) Author
2024-10-15 05:48:28
NNN. The number of children in the study (5367) is clearly stated followed by information about the percentages affected. No claim is made about these numbers reflecting children on a population level - so caveat does not apply. Study goal is to articulate LC in children. [Link] NEEDS_MORE_RATINGS(3-0-0) Author